Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh (M2PT34) Dividend Date & History
Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh (BR:M2PT34) has no upcoming dividends
Other Large Cap Stocks Paying Dividends
| Name | Dividend Yield | Smart Score | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Top Analysts' Price Target | Follow |
|---|---|---|---|---|---|---|---|---|---|
 MO | $4.29 (5.50%) | $129.80B | 16.12 | +36.58% | Buy | ||||
 T | $1.11 (5.18%) | $144.23B | 11.57 | -13.25% | Buy | ||||
 XRX | $0.10 (6.82%) | $192.38M | -0.17 | -52.59% | Neutral | ||||
 IBM | $6.74 (2.61%) | $243.66B | 21.66 | -16.85% | Buy | ||||
 CVX | $7.05 (2.99%) | $465.33B | 17.18 | +53.41% | StrongBuy | ||||
 EOG | $4.08 (2.46%) | $86.83B | 12.81 | +56.97% | Buy | ||||
 ET | $1.35 (6.43%) | $72.00B | 12.57 | +24.69% | StrongBuy | ||||
 HESM | $3.09 (9.44%) | $6.74B | 11.20 | -4.19% | Sell | ||||
 ARCC | $1.92 (10.05%) | $13.80B | 15.66 | -5.16% | StrongBuy |
FAQ
How much is Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh's dividend?
Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh (BR:M2PT34) does not pay a dividend
When is Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh ex-dividend date?
Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh (BR:M2PT34) does not pay a dividend.
When is Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh dividend payment date?
Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh (BR:M2PT34) does not pay a dividend.
Does Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh have sufficient earnings to cover their dividend?
Medical Properties Trust, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh (BR:M2PT34) does not pay a dividend.